Modulation of the pathology of late xenograft rejection by PAF-antagonist UR-12670 in the hamster-to-rat liver xenotransplant model: PAF antagonist alleviates xenogeneic rejection

APMIS

Volumn 111, Issue 3, 2003, Pages 371-381

  Ginestà, Mireia M ^a   Molleví, David G ^a   Serrano, Teresa ^b   Bas, Jordi ^b   Mestre, Mariona ^b   Ribas, Yolanda ^a   Figueras, Joan ^a   Jaurrieta, Eduardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Hamster to rat; Histology; Immunofluorescence; Immunosuppression; Liver xenotransplantation; LXR; Lymphocyte; PAF; PAF antagonist; UR 12670; Xenoantibodies

Indexed keywords

ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; UR 12670;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BLEEDING; CELL LOSS; DRUG MECHANISM; DRUG SCREENING; FLOW CYTOMETRY; GRAFT REJECTION; HAMSTER; HISTOLOGY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL; LIVER CONGESTION; LIVER NECROSIS; LIVER SINUSOID; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; XENOGRAFT;

ALANINE TRANSAMINASE; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODY SPECIFICITY; ASPARTATE AMINOTRANSFERASES; BLOTTING, WESTERN; CRICETINAE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT SURVIVAL; IMIDAZOLES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER; LIVER TRANSPLANTATION; MALE; MESOCRICETUS; PLATELET ACTIVATING FACTOR; PYRIDINES; RATS; RATS, INBRED LEW; SERUM ALBUMIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 0038218180     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.t01-1-1110201.x     Document Type: Article

References (32)

1. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987;2:97-145.
2. Pignol B, Henane S, Mencia-Huerta JM, Braquet P. Effect of long-term treatment with platelet-activating factor on cytokine production by rat spleen cells. Int Arch Allergy Appl Immunol 1989;88:161-3.
3. Sanfilippo F, Kolbeck PC, Vaughn WK, Bollinger RR. Renal allograft cell infiltrates associated with irreversible rejection. Transplantation 1985;40:679-85.
4. Pignol B, Henane S, Mencia-Huerta JM, Rola-Pleszczynsky M, Braquet P. Effect of PAF-acether (platelet activating factor) and its specific antagonist BN-52021 in interleukin 1 (IL-1) synthesis and release by rat monocytes. Prostaglandins 1987 33:931-9.
5. Foegh ML, Khirabadi BS, Rowles JR, Braquet P, Ramwell PW. Prolongation of cardiac allograft survival with BN52021, a specific antagonist of platelet activating factor. Transplantation 1986;42:86-8.
6. Butterly DW, Spurney RF, Ruiz P, Pirotzky E, Braquet P, Coffman TM. Role of platelet activating factor in kidney transplant rejection in the rat. Kidney Int 1995; 48:337-43.
7. Walcher F, Marzi I, Fischer R, Bauer M, Larsen R. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation. J Surg Res 1996;61:244-9.
8. Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, et al. Inflammatory roles of P-selectin. J Clin Invest 1993;92:559-70.
9. Milhoan KA, Lane TA, Bloor CM. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. Am J Physiol 1992;263:H956-62.
10. Makowka L, Chapman FA, Cramer DV, Qian SG, Sun H, Starzl TE. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation 1990;50:359-65.
11. O'Hair DP, Roza AM, Pieper GM, Komorowski R, Moore G, McManus RP, et al. Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection. Transplant Proc 1992;24:702-3.
12. O'Hair DP, Roza AM, Komorowski R, Moore G, McManus RP, Johnson CP, et al. Tulopafant, a PAF receptor antagonist, increases capillary patency and prolongs survival in discordant cardiac xenotransplants. J Lipid Mediat 1993;7:79-84.
13. Saumweber DM, Bergmann R, Gokel M, Brecht HM, Hammer C. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS. Transplant Proc 1991;23:576-8.
14. Cruzado JM, Torras J, Riera M, Lloberas N, Herrero I, Condom E, et al. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. Clin Exp Immunol 1998;113:136-44.
15. Herrero-Fresneda I, Torras J, Lloberas N, Riera M, Cruzado JM, Condom E, et al. Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor. Transplantation 2000;70:1624-31.
16. Carceller E, Merlos M, Giral M, Balsa D, Garcia-Rafanell J, Forn J. Design, synthesis and structure-activity relationship studies of novel 1-[[1-(3,3-diphenylpropanoyl)-4-piperidyl]methyl]-1-H-2-methylimidazol[4,5-c] pyridine derivates as potent, orally active platelet-activating factor antagonists. J Med Chem 1996;39:487-93.
17. Balsa D, Merlos M, Giral M, Ferrando R, Garcia-Rafanell J, Forn J. Effects of a new antagonist of platelet-activating factor, UR-12670, on several endotoxic shock markers in rats. Drug Exp Clin Res 1997;22:191-9.
18. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28:47-50.
19. Kamada N. Surgical techniques for rat liver transplantation. In: Kamada N, editor. Experimental Liver Transplantation. Boca Raton: CRC Press, 1988:7-18.
20. Sankary HN, Yin DP, Chong ASF, Li Ma L, Blinder L, Shen J, et al. FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation 1998;66:832-7.
21. Valdivia LA, Monden M, Gotoh M, Hasuike Y, Kubota N, Ichikawa T, et al. Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration. Transplantation 1987;44:759-63.
22. Collins BH, Chari RS, Magee JC, Harland RC, Lindman BJ, Logan JS Mechanisms of injury in porcine livers perfused with blood of humans with fulminant hepatic failure. Transplantation 1994;58:1162-71.
23. Demetris AJ, Markus BH. Immunopathology of liver transplantation. Crit Rev Immunol 1989;9:67-92.
24. Houssin D, Bellon B, Brunaud MD, Gugenheim J, Settaf A, Meriggi F, et al. Interactions between liver allografts and lymphocytotoxic antibodies in inbred rats. Hepatology 1986;6:994-8.
25. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-82.
26. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992;340:876-7.
27. Patke CL, Green CG, Shearer WT. Differential effects of interleukin-2 and interleukin-4 on immunomodulatory role of platelet-activating factor in human B-cells. Clin Diagn Lab Immunol 1994;1:424-32.
28. Nourshargh S, Larkin SW, Das A, Williams TJ. Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood 1995;85:2553-8.
29. Takada Y, Boudjema K, Jaeck D. Effects of platelet-activating factor antagonist on preservation reperfusion injury of the graft in porcine orthotopic liver transplantation. Transplantation 1995;59:10-6.
30. Mollevi DG, Ribas Y, Ginesta MM, Serrano T, Mestre M, Vidal A, et al. Heart and liver transplantation under low-dose tacrolimus. Graft survival after withdrawal of immunosuppression. Transplantation 2001;71:217-23.
31. Murase N, Starzl TE, Demetris AJ, Valdivia L, Tanabe M, Cramer D et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993;55:701-8.
32. Chong ASF Shen J, Xiao F, Blinder L, Wei L, Sankary H, et al. Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation 1996;62:90-6.